Jefferies Boosts Atai Life Sciences Price Target to $10 on FDA Breakthrough Win

Jefferies raises Atai Life Sciences price target to $10 following FDA Breakthrough Therapy Designation for depression drug BPL-003, citing 72% approval rate for BTD drugs.